TeraCyte bridges biology and AI through a proprietary platform that transforms live cell behavior into BioTokens™-structured, dynamic data for AI modeling. Powered by a proprietary silicon imaging array chip, TeraCyte captures real-time, high-resolution temporal data from millions of live cells. Backed by a world-class team and partnerships with Harvard, CalTech, and Weizmann, TeraCyte's hardware-software integration is driving predictive breakthroughs in drug development, bioproduction, and diagnostics across a $15B+ market opportunity.